News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
75,295 Results
Type
Article (2283)
Company Profile (21)
Press Release (72991)
Section
Business (32572)
Career Advice (29)
Deals (5139)
Drug Delivery (2)
Drug Development (9329)
Employer Resources (7)
FDA (1617)
Job Trends (1935)
News (46345)
Policy (2642)
Tag
Academia (199)
Academic (1)
Accelerated approval (5)
Allergies (20)
Alliances (2947)
ALS (6)
Alzheimer's disease (225)
Antibody-drug conjugate (ADC) (43)
Approvals (1715)
Artificial intelligence (25)
Autoimmune disease (12)
Automation (4)
Bankruptcy (12)
Best Places to Work (1827)
BIOSECURE Act (1)
Biosimilars (12)
Biotechnology (9)
Bladder cancer (42)
Brain cancer (2)
Breast cancer (202)
Cancer (759)
Cardiovascular disease (38)
Career advice (29)
Career pathing (3)
CAR-T (13)
CDC (3)
Cell therapy (51)
Cervical cancer (7)
Clinical research (8635)
Collaboration (116)
Compensation (64)
Complete response letters (1)
COVID-19 (200)
CRISPR (7)
C-suite (21)
Cystic fibrosis (18)
Data (1002)
Depression (15)
Diabetes (58)
Diagnostics (816)
Digital health (6)
Diversity, equity & inclusion (1)
Drug discovery (19)
Drug pricing (7)
Duchenne muscular dystrophy (25)
Earnings (29504)
Editorial (3)
Employer branding (1)
Employer resources (6)
Events (8334)
Executive appointments (31)
FDA (2170)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (62)
Gene editing (13)
Generative AI (1)
Gene therapy (62)
GLP-1 (113)
Government (328)
Guidances (266)
Healthcare (2430)
HIV (14)
Huntington's disease (10)
IgA nephropathy (18)
Immunology and inflammation (32)
Immuno-oncology (6)
Indications (15)
Infectious disease (232)
Inflammatory bowel disease (16)
Influenza (14)
Intellectual property (21)
Interviews (3)
IPO (3791)
IRA (2)
Job creations (179)
Job search strategy (25)
Kidney cancer (5)
Labor market (10)
Layoffs (35)
Legal (416)
Liver cancer (10)
Lung cancer (106)
Lymphoma (83)
Management (2)
Manufacturing (30)
MASH (19)
Medical device (1856)
Medtech (1863)
Mergers & acquisitions (1438)
Metabolic disorders (115)
Multiple sclerosis (27)
NASH (3)
Neurodegenerative disease (30)
Neuropsychiatric disorders (10)
Neuroscience (359)
NextGen: Class of 2026 (493)
Non-profit (261)
Now hiring (2)
Obesity (37)
Opinion (5)
Ovarian cancer (21)
Pain (15)
Pancreatic cancer (34)
Parkinson's disease (25)
Partnered (1)
Patents (34)
Patient recruitment (22)
Peanut (8)
People (2495)
Pharmaceutical (6)
Pharmacy benefit managers (1)
Phase I (2020)
Phase II (3517)
Phase III (3778)
Pipeline (1452)
Policy (7)
Postmarket research (345)
Preclinical (653)
Press Release (1)
Prostate cancer (31)
Psychedelics (1)
Radiopharmaceuticals (28)
Rare diseases (84)
Real estate (300)
Recruiting (3)
Regulatory (2329)
Reports (19)
Research institute (196)
Resumes & cover letters (2)
Rett syndrome (5)
RSV (10)
Schizophrenia (23)
Series A (5)
Series B (8)
Service/supplier (1)
Sickle cell disease (7)
Special edition (3)
Spinal muscular atrophy (37)
Sponsored (4)
Startups (146)
State (1)
Stomach cancer (3)
Supply chain (10)
Tariffs (6)
The Weekly (1)
Vaccines (63)
Venture capital (8)
Weight loss (23)
Women's health (6)
Worklife (2)
Date
Last 7 days (41)
Last 30 days (132)
Last 365 days (4708)
2026 (99)
2025 (4698)
2024 (5391)
2023 (6383)
2022 (7151)
2021 (7479)
2020 (6737)
2019 (5310)
2018 (3879)
2017 (3293)
2016 (2548)
2015 (3267)
2014 (2238)
2013 (1422)
2012 (1805)
2011 (2109)
2010 (1959)
Location
Africa (46)
Alabama (8)
Arizona (22)
Asia (3866)
Australia (486)
California (1525)
Canada (394)
China (95)
Colorado (65)
Connecticut (75)
Delaware (89)
Europe (14827)
Florida (205)
Georgia (43)
Idaho (5)
Illinois (80)
India (2)
Indiana (123)
Japan (80)
Kansas (16)
Kentucky (6)
Louisiana (7)
Maine (15)
Maryland (158)
Massachusetts (1048)
Michigan (33)
Minnesota (93)
Missouri (17)
Montana (4)
Nebraska (1)
Nevada (10)
New Hampshire (11)
New Jersey (551)
New York (372)
North Carolina (176)
Northern California (855)
Ohio (40)
Oklahoma (1)
Oregon (6)
Pennsylvania (294)
Puerto Rico (1)
Rhode Island (1)
South America (71)
South Carolina (4)
Southern California (568)
Tennessee (18)
Texas (217)
United States (5413)
Utah (40)
Virginia (19)
Washington D.C. (6)
Washington State (125)
Wisconsin (8)
75,295 Results for "46".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immutep Receives A$4.6 million R&D Tax Incentive from French Government
November 4, 2025
·
1 min read
Press Releases
ReviR Therapeutics Receives $4.6 Million CIRM Grant to Advance Huntington’s Disease Treatment and Announces Key Development Milestone
November 21, 2025
·
4 min read
Press Releases
Rarity PBC Raises $4.6 Million Seed Financing to Advance Gene Therapy for ADA-SCID
October 30, 2025
·
4 min read
Press Releases
POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer’s Immunotherapy
October 2, 2025
·
3 min read
Press Releases
Herbal Medicinal Products Market to Hit $326.46 Billion by 2032, at a CAGR of 7.4%, says Coherent Market Insights
November 3, 2025
·
1 min read
Press Releases
NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues
August 12, 2025
·
9 min read
Press Releases
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
July 10, 2025
·
5 min read
Press Releases
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer
September 25, 2025
·
6 min read
Press Releases
Cell and Gene Therapy Market Size Rapidly Approaching $117.46 Billion by 2034
June 25, 2025
·
1 min read
Press Releases
LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference
May 29, 2025
·
1 min read
1 of 7,530
Next
